Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) for potential violations of federal securities laws. This follows a report by Scorpion Capital raising concerns about Harmony's narcolepsy drug, Wakix.
December 18, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Harmony Biosciences is under investigation by Levi & Korsinsky for potential securities law violations related to its narcolepsy drug, Wakix, following a critical report by Scorpion Capital.
The investigation by Levi & Korsinsky into Harmony Biosciences for potential securities law violations is significant, especially following Scorpion Capital's report. This could lead to legal challenges and affect investor confidence, likely impacting HRMY's stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100